Our data demonstrated that inhibiting kynurenine 3-monooxygenase (KMO), a metabolic enzyme involved in the kynurenine pathway (KP), improved mitochondrial dynamics and inhibited mitophagy after stroke 24. This evidence concerns the gene KMO and Stroke.